Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-30

Clinical Trial Update: Lifestyle Advises Sent Via Email in Attempt of Improving A1C in DM2 Patients [NA]

View source ↗

Summary

A completed trial evaluated whether sending lifestyle advice emails to adults with type 2 diabetes can improve A1C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED